Access Statistics for James K. Hammitt

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis 0 0 0 0 1 1 7 10
Accounting for the distribution of benefits & costs in benefit-cost analysis 1 2 4 47 4 5 19 120
Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards 0 0 0 120 3 5 24 368
Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards 0 0 0 16 3 4 21 112
Combining Experts’ Judgments: Comparison of Algorithmic Methods using Synthetic Data 0 0 0 18 5 5 22 90
Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year 0 0 0 27 2 3 21 35
Consistent Valuation of a Reduction in Mortality Risk using Values per Life, Life Year, and Quality-Adjusted Life Year 0 0 0 0 2 2 12 18
Contingent Valuation and the Economic Value of Air-Pollution-Related Health Risks in China 0 0 1 166 2 3 20 563
Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness 0 0 0 12 2 9 21 78
Diminishing Willingness to Pay per Quality-Adjusted Life Year: Valuing Acute Foodborne Illness 0 0 0 26 4 4 19 92
Dinner with Bayes: On the Revision of Risk Beliefs 0 0 0 35 2 3 14 77
Does risk aversion increase the value of mortality risk? 0 0 0 3 1 1 20 44
Downside Risk Aversion vs Decreasing Absolute Risk Aversion: An Intuitive Exposition 0 0 0 15 1 1 11 26
Downside risk aversion vs decreasing absolute risk aversion: an intuitive exposition 0 0 0 0 1 1 4 7
Economic Evaluation with Hormetic, Hockey-Stick, and Linear Response Functions: An Application to Radon in Drinking Water 0 0 0 4 0 0 6 61
Economic Evaluation with Hormetic, Hockey-Stick, and Linear Response Functions: An Application to Radon in Drinking Water 0 0 0 7 3 3 7 81
Effects of Disease Type and Latency on the Value of Mortality Risk 0 0 0 84 0 0 11 489
Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults 0 0 0 0 3 3 7 17
Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults 0 0 0 85 0 1 12 216
Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults 0 0 0 5 5 6 14 42
Expert Elicitation of the Value per Statistical Life in an Air Pollution Context 0 0 0 62 3 3 15 234
Expert Elicitation of the Value per Statistical Life in an Air Pollution Context 0 0 0 46 1 2 20 95
Fair Innings: An Empirical Test 1 1 1 14 2 2 23 33
Fair Innings? The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime 0 0 0 14 5 5 18 58
Fair Innings? The Utilitarian and Prioritarian Value of Risk Reduction over a Whole Lifetime 0 0 0 3 0 2 7 37
Fatality Risk Regulation 0 0 0 10 4 4 20 57
Health Information and Subjective Survival Probability: Evidence from Taiwan 0 0 0 42 1 1 24 289
Health Insurance and Households' Precautionary Behaviors - An Unusual Natural Experiment 0 0 0 158 0 2 11 633
How to Balance Lives and Livelihoods in a Pandemic 0 0 0 0 0 0 3 5
How to Balance Lives and Livelihoods in a Pandemic 0 0 0 0 1 1 7 8
Is Survival a Luxury Good? Income Elasticity of the Value per Statistical Life 0 1 1 28 2 7 27 66
Madison and climate change policy 0 0 0 0 0 0 4 11
Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve 0 0 0 0 2 3 9 15
Monetary values of increasing life expectancy: sensitivity to shifts of the survival curve 0 0 0 10 1 3 10 23
Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys 0 0 0 0 2 3 7 45
Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys 0 0 0 28 1 2 14 115
Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys 0 0 0 0 0 0 5 21
Prevention, Treatment, and Palliative Care: The Relative Value of Health Improvements under Alternative Evaluation Frameworks 0 0 0 4 2 4 15 27
Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks 0 0 0 0 4 4 17 21
Prioritarianism and fatality risk regulation 0 0 0 0 2 3 6 23
Risk and Choice: A Research Saga 0 0 0 85 4 6 31 159
Risk and Choice: A Research Saga 0 0 0 89 3 4 16 150
Risk-Risk Tradeoffs in Fish Consumption: Can You Have the Cake and Eat It Too? 0 0 0 18 3 5 11 73
Statistical vs. Identified Lives in Benefit-Cost Analysis 0 0 0 97 1 3 14 573
Statistical vs. Identified Lives in Benefit-Cost Analysis 0 1 1 22 0 2 13 158
Sub-Saharan Africa Refinery Study 0 0 0 1 1 1 6 8
The Effect of Prenatal Exposure to Radiation on Birth Outcomes: Exploiting a Natural Experiment in Taiwan 0 0 0 26 2 2 23 67
The Intergenerational Transmission of Education: Evidence from Taiwanese Adoptions 0 0 0 67 1 2 14 97
The Intergenerational Transmission of Education: Evidence from Taiwanese Adoptions 0 0 0 65 0 1 12 166
The Modest Effects of Fact Boxes on Cancer Screening 0 0 0 0 1 2 13 16
The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair 0 0 0 0 3 3 5 6
The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair 0 0 0 0 0 1 3 7
The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach 0 0 0 55 2 3 14 91
The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach 0 0 0 47 1 1 11 147
The Social Value of Mortality Risk Reduction: VSL vs. the Social Welfare Function Approach 0 0 0 27 1 1 11 125
The Value of Cancer Prevention vs Treatment 0 0 0 44 4 5 25 178
The Value of Risk Reduction: New Tools for an Old Problem 0 0 0 110 3 4 29 203
The Welfare Value of FDA’s Mercury-in-Fish Advisory: A Dynamic Reanalysis 0 0 0 15 2 4 18 200
The economics in 'Global Health 2035': a sensitivity analysis of the value of a life year estimates 0 0 0 53 4 4 11 66
The value of disease prevention vs treatment 0 0 0 0 0 0 11 23
The value of disease prevention vs treatment 0 0 0 0 0 1 6 32
The value of risk reduction: new tools for an old problem 0 0 0 0 2 2 10 40
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates 0 0 0 1 0 0 1 6
Valuation of the Risk of SARS in Taiwan 0 0 0 94 2 2 9 422
Valuing COVID-19 Morbidity Risk Reductions 0 0 0 0 0 1 7 10
Valuing Children’s Fatality Risk Reductions 0 0 0 31 1 1 6 37
Valuing Morbidity Risk: Willingness to Pay per Quality-Adjusted Life Year 0 0 0 33 1 1 8 116
Valuing Mortality Risk Reductions: Progress and Challenges 0 0 0 45 1 1 7 141
Valuing Mortality Risk Reductions: Progress and Challenges 0 0 0 57 1 3 17 127
Valuing Mortality Risk Reductions:Progress and Challenges 0 0 0 7 0 1 10 121
Valuing Mortality Risk in China: Comparing Stated-Preference Estimates from 2005 and 2016 0 0 0 33 2 2 12 95
Valuing Non-fatal Health Risks: Monetary and Health-Utility Measures 0 0 0 50 3 4 17 68
Valuing mortality risk in the time of covid-19 0 0 0 38 4 9 32 108
Valuing non-marginal changes in mortality and morbidity risk 0 0 0 0 2 2 9 16
Valuing non-marginal changes in mortality and morbidity risk 0 0 0 5 2 2 23 38
Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety 0 0 0 5 3 6 16 77
Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety 0 0 0 29 0 2 17 163
Willingness to Pay for Car Safety: Sensitivity to Time Framing 0 0 0 38 1 4 17 188
Willingness to pay and QALYs: What can we learn about valuing foodborne risk? 0 0 0 10 3 4 18 78
Willingness to pay and QALYs: What can we learn about valuing foodborne risk? 0 0 0 38 0 2 9 143
Total Working Papers 2 5 8 2,424 141 215 1,096 8,901


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Benefit‐Cost Analysis of Retrofitting Diesel Vehicles with Particulate Filters in the Mexico City Metropolitan Area 0 0 0 3 4 4 8 20
A Comparison of Organic and Conventional Fresh Produce Buyers in the Boston Area 0 0 0 6 1 1 7 27
A Theoretical Foundation for Life‐Cycle Assessment: Recognizing the Role of Values in Environmental Decision Making 0 0 1 11 4 5 12 26
A new meta-analysis on the WTP/WTA disparity 0 0 1 141 4 10 31 490
Accounting for the Distribution of Benefits and Costs in Benefit–Cost Analysis 0 0 0 4 0 1 20 42
Adding an Economic Dimension to Risk Assessment: Discussion 0 0 0 10 3 3 8 31
Admissible utility functions for health, longevity, and wealth: integrating monetary and life-year measures 0 1 1 33 0 4 8 129
Aggregation Biases in Estimates of the Value per Statistical Life: Evidence from Longitudinal Matched Worker-Firm Data in Taiwan 0 1 2 23 0 2 11 106
Are The Costs of Proposed Environmental Regulations Overestimated? Evidence from the CFC Phaseout 0 0 1 54 1 3 9 210
Assessing Preferences for Prevention versus Treatment Using Willingness to Pay 0 0 0 1 0 1 2 5
Attention to Distribution in U.S. Regulatory Analyses 0 0 1 10 6 7 15 60
Background Risks and the Value of a Statistical Life 0 0 0 69 3 3 13 251
Behavioral Economics and Regulatory Analysis 0 0 0 3 1 2 10 29
Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards 0 0 0 10 2 2 8 51
Behavioral Economics and the Conduct of Benefit-Cost Analysis: Towards Principles and Standards 0 0 3 77 4 7 19 251
Combining Experts’ Judgments: Comparison of Algorithmic Methods Using Synthetic Data 1 1 1 1 3 3 16 30
Compensating Wage Differentials with Unemployment: Evidence from China 1 1 1 57 4 4 18 205
Computer use and wages: evidence from Taiwan 0 0 0 42 1 1 10 202
Conducting Benefit-Cost Analysis in Low- and Middle-Income Countries: Introduction to the Special Issue 0 0 0 17 1 1 6 45
Consistent valuation of a reduction in mortality risk using values per life, life year, and quality‐adjusted life year 0 1 1 1 2 6 19 25
Consumer Willingness to Pay for Low‐Pesticide Fresh Produce in Taiwan 0 0 0 66 1 1 13 201
Consumer’s Guide to Regulatory Impact Analysis: Ten Tips for Being an Informed Policymaker 0 0 0 3 2 2 8 24
Contingent valuation of a Taiwanese wetland 0 0 4 134 1 2 13 321
DISCOUNTING HEALTH AND COST‐EFFECTIVENESS ANALYSIS: A RESPONSE TO NORD 0 1 1 2 1 2 9 41
Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness 0 0 0 1 1 2 7 13
Dinner with Bayes: On the revision of risk beliefs 0 0 0 3 0 0 10 50
Discounting health increments 0 1 1 13 1 2 6 57
Do small plants grow faster? Evidence from the Taiwan electronics industry 0 0 0 85 1 1 14 416
Does risk aversion increase the value of mortality risk? 0 0 0 44 1 1 6 203
Downside risk aversion vs decreasing absolute risk aversion: an intuitive exposition 0 0 0 3 0 0 12 21
EXPORTING AND PRODUCTIVITY GROWTH: EVIDENCE FROM THE TAIWAN ELECTRONICS PLANTS 0 0 0 31 2 2 14 133
Effects of Disease Type and Latency on the Value of Mortality Risk 0 0 0 35 1 1 8 262
Effects of Health and Longevity on Financial Risk Tolerance 0 0 0 4 2 2 11 35
Environmental false alarms and policy implications 0 0 0 8 2 2 5 26
Equity, Efficiency, Uncertainty, and the Mitigation of Global Climate Change 0 0 0 1 2 2 9 14
Erratum to: Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety 1 1 1 3 2 2 13 38
Estimated hedonic wage function and value of life in a developing country 0 0 1 194 2 3 16 610
Estimating General-population Utilities Using One Binary-gamble Question per Respondent 0 0 0 0 1 1 7 8
Evaluating Willingness to Pay as a Measure of the Impact of Dyslexia in Adults 0 0 0 3 1 4 10 48
Expert Elicitation of the Value per Statistical Life in an Air Pollution Context 0 0 0 2 1 1 17 46
Export activity and productivity: Evidence from the Taiwan electronics industry 0 0 0 76 1 2 22 289
Extrapolating the Value Per Statistical Life Between Populations: Theoretical Implications 0 0 0 5 0 1 3 29
Fair innings? The utilitarian and prioritarian value of risk reduction over a whole lifetime 0 0 0 0 4 4 20 41
Family background and returns to schooling in Taiwan 0 0 0 39 0 0 15 146
Finding the Optimal Multiple-test Strategy Using a Method Analogous to Logistic Regression 0 0 0 0 2 2 5 7
From Benefit–Cost Analysis to Social Welfare: A Pragmatic Approach 0 0 6 6 1 1 18 18
Health Information and Subjective Survival Probability: Evidence from Taiwan 0 0 0 0 4 4 14 58
Households’ precautionary behaviors—the effects of the introduction of National Health Insurance in Taiwan 0 0 0 48 1 2 15 196
Hurricane risk perceptions and housing market responses: the pricing effects of risk-perception factors and hurricane characteristics 0 0 1 12 0 1 14 46
Implications of the WTP–WTA Disparity for Benefit–Cost Analysis 0 0 1 14 1 1 8 45
Introduction to Special Issue on Life Cycle Assessment and Risk Analysis 0 0 0 0 2 2 6 16
Introduction to the Special Series on Research Synthesis: A Cross‐Disciplinary Approach 0 0 0 0 3 3 10 16
Introduction to the Special Series on Risk, Perception, and Response 0 0 0 0 0 0 4 6
Is survival a luxury good? Income elasticity of the value per statistical life 0 0 0 3 4 6 18 37
Limitations of Acceptability Curves for Presenting Uncertainty in Cost-Effectiveness Analysis 0 0 0 0 0 0 5 10
Limitations to Empirical Extrapolation Studies: The Case of BMD Ratios 0 0 0 0 0 1 8 11
Major Factors Influencing the Health Impacts from Controlling Air Pollutants with Nonlinear Chemistry: An Application to China 0 0 0 0 3 12 19 23
Measuring Health Preferences for Use in Cost-Utility and Cost-Benefit Analyses of Interventions in Children 0 0 0 57 2 3 7 206
Monetary values of increasing life expectancy: Sensitivity to shifts of the survival curve 0 0 0 0 1 3 16 23
Mother's willingness to pay for her own and her child's health: a contingent valuation study in Taiwan 0 0 0 4 1 1 10 219
National Health Insurance and Technology Adoption: Evidence from Taiwan 0 0 0 30 1 1 14 160
National Health Insurance and precautionary saving: evidence from Taiwan 0 0 2 218 3 6 21 640
Peeling back the onion: Using latent class analysis to uncover heterogeneous responses to stated preference surveys 0 0 1 8 0 0 20 110
Perceived Risks of Conventional and Organic Produce: Pesticides, Pathogens, and Natural Toxins 1 1 2 10 3 3 10 32
Perceived risk and value of workplace safety in a developing country 0 0 1 16 1 1 16 82
Positive versus Normative Justifications for Benefit-Cost Analysis: Implications for Interpretation and Policy 0 0 1 59 1 2 24 203
Precautionary Regulation in Europe and the United States: A Quantitative Comparison 0 0 0 2 0 0 9 50
Preferences for life-expectancy gains: Sooner or later? 0 0 0 15 6 6 12 80
Premature Deaths, Statistical Lives, and Years of Life Lost: Identification, Quantification, and Valuation of Mortality Risks 0 0 0 1 1 1 15 27
Prevention, treatment, and palliative care: The relative value of health improvements under alternative evaluation frameworks 0 0 0 1 2 3 7 15
Pricing Lives: Guideposts for a Safer Society. W. Kip Viscusi (2018). Princeton, NJ: Princeton University Press 0 1 2 24 1 2 10 51
Principles for Conduct of Pest Risk Analyses: Report of an Expert Work hop 0 0 0 2 2 11 19 26
QALYs Versus WTP 0 0 3 13 2 4 15 46
Research Synthesis and the Value per Statistical Life 0 0 0 11 2 2 12 57
Residential Building Codes, Affordability, and Health Protection: A Risk‐Tradeoff Approach 0 0 0 0 0 1 17 25
Risk Perceptions and Food Choice: An Exploratory Analysis of Organic‐ Versus Conventional‐Produce Buyers 0 0 0 5 3 3 13 34
Risk Premiums for Environmental Liability: Does Superfund Increase the Cost of Capital? 0 0 1 58 2 2 12 208
Risk and choice: A research saga 0 0 1 65 0 1 12 214
Risk/Risk Trade‐offs in Pesticide Regulation: An Exploratory Analysis of the Public Health Effects of a Ban on Organophosphate and Carbamate Pesticides 0 0 0 1 0 1 8 19
Safety Impacts of SUVs, Vans, and Pickup Trucks in Two‐Vehicle Crashes 0 0 0 3 1 1 5 24
Selecting Human Health Metrics for Environmental Decision‐Support Tools 0 0 0 0 2 4 9 16
Sensitivity of willingness to pay to the magnitude of risk reduction: a Taiwan­United States comparison 0 0 0 3 3 3 21 47
Skills of the trade: valuing health risk reductions in benefit-cost analysis 0 0 0 33 2 2 14 137
Skills of the trade: valuing health risk reductions in benefit-cost analysis 0 0 0 4 1 1 14 44
Statistical Analysis of Cost-Effectiveness Data by A. R. WILLAN, and A. H. BRIGGS 0 0 0 1 1 1 3 17
Statistical vs. identified lives in benefit-cost analysis 0 0 0 46 2 2 16 284
Subjective‐Probability‐Based Scenarios for Uncertain Input Parameters: Stratospheric Ozone Depletion 0 0 0 0 3 3 8 20
The Economic Value of Air-Pollution-Related Health Risks in China: A Contingent Valuation Study 2 2 2 171 6 8 20 660
The Expected Value of Information and the Probability of Surprise 0 0 0 3 1 1 7 23
The Impact of Advanced Technology Adoption on Wage Structures: Evidence from Taiwan Manufacturing Firms 0 0 1 2 1 1 10 21
The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations 0 0 0 8 4 5 37 83
The Income Elasticity of the Value per Statistical Life: Transferring Estimates between High and Low Income Populations 0 1 2 89 5 6 41 419
The Long-Run Discount Rate Controversy 0 2 3 49 4 8 22 191
The Right Numeraire or the Just Weights? How to Make BCA Rational and Fair 0 0 0 1 0 1 6 8
The changing risk perception towards nuclear power in China after the Fukushima nuclear accident in Japan 0 0 1 9 0 2 15 57
The economic value of fatal and non‐fatal occupational risks in Mexico City using actuarial‐ and perceived‐risk estimates 0 0 4 60 2 2 11 236
The effect of prenatal exposure to radiation on birth outcomes: exploiting a natural experiment in Taiwan 0 0 0 7 1 1 12 52
The future costs of methane emissions 1 1 1 1 2 2 9 18
The impact of foreign direct investment in China on employment adjustments in Taiwan: Evidence from matched employer–employee data 0 0 0 54 2 5 24 269
The intergenerational transmission of education: Evidence from Taiwanese adoptions 0 0 0 23 4 5 21 102
The modest effects of fact boxes on cancer screening 0 1 1 3 2 4 17 27
The price elasticity of opium in Taiwan, 1914-1942 1 1 1 59 1 2 26 236
The social value of mortality risk reduction: VSL versus the social welfare function approach 0 0 0 8 2 3 17 84
The value of disease prevention vs treatment 0 0 0 22 2 3 11 89
The value of international cooperation for abating global climate change 0 0 0 26 2 2 11 131
The value of risk reduction: new tools for an old problem 0 0 1 11 2 2 14 76
The welfare value of FDA's mercury-in-fish advisory: A dynamic reanalysis 0 0 0 5 5 5 13 93
Theoretical bounds on the value of improved health 1 1 1 7 2 4 16 50
Tiered Chemical Testing: A Value of Information Approach 0 0 0 0 0 0 4 5
Tools for Comparative Analysis of Alternatives: Competing or Complementary Perspectives? 0 0 0 0 2 2 12 24
Trends in Author-Reported Cost-Effectiveness Thresholds in the United States from 1995 to 2018: Implications for Discount Rates 0 0 0 1 0 0 5 11
Understanding differences in estimates of the value of mortality risk 0 0 0 5 1 1 4 23
Use of Contingent Valuation to Elicit Willingness-to-Pay for the Benefits of Developmental Health Risk Reductions 0 0 0 40 1 8 12 132
Using Life Expectancy to Communicate Benefits of Health Care Programs in Contingent Valuation Studies 0 0 0 0 1 1 7 8
Valuation of the risk of SARS in Taiwan 0 0 0 38 2 2 9 259
Valuing COVID-19 Morbidity Risk Reductions 0 0 0 1 1 1 7 12
Valuing Changes in Mortality Risk: Lives Saved Versus Life Years Saved 0 1 3 47 3 7 18 166
Valuing Children’s Fatality Risk Reductions 0 0 0 3 1 1 7 21
Valuing Mortality Risk Reductions in Global Benefit-Cost Analysis 0 0 0 16 3 4 17 67
Valuing Mortality Risk Reductions: Progress and Challenges 0 0 0 33 2 4 18 210
Valuing Mortality-Risk Reduction: Using Visual Aids to Improve the Validity of Contingent Valuation 0 0 1 122 3 3 15 629
Valuing Non-Fatal Health Risks: Monetary and Health-Utility Measures 0 0 0 0 2 3 14 28
Valuing Reductions in Fatal Illness Risks: Implications of Recent Research 0 0 1 24 1 5 13 86
Valuing fatal risks to children and adults: Effects of disease, latency, and risk aversion 0 0 3 94 1 3 21 297
Valuing mortality risk in China: Comparing stated-preference estimates from 2005 and 2016 0 0 1 14 1 2 10 81
Valuing mortality risk in the time of COVID-19 0 0 0 6 1 1 16 65
Valuing non-marginal changes in mortality and morbidity risk 0 0 0 1 1 1 8 16
Valuing nonfatal health risk as a function of illness severity and duration: Benefit transfer using QALYs 0 0 1 34 3 4 20 113
Valuing the Risk of Death from Terrorist Attacks 0 0 0 2 4 6 19 38
Willingness to Pay and QALYs: What Can We Learn about Valuing Foodborne Risk? 0 0 0 3 0 2 17 59
Willingness to Pay and Sensitivity to Time Framing: A Theoretical Analysis and an Application on Car Safety 0 0 1 7 0 0 17 87
Willingness to Pay for Food Safety: Sensitivity to Duration and Severity of Illness 0 0 0 74 5 6 12 198
Willingness to Pay for Health Protection: Inadequate Sensitivity to Probability? 0 0 0 135 3 3 7 369
Willingness to pay for weight-control treatment 0 0 0 43 2 2 15 172
Willingness‐to‐pay for predictive tests with no immediate treatment implications: a survey of US residents 0 0 0 1 2 2 12 75
Worker flows and job flows in Taiwan 0 0 0 14 2 3 18 96
Worker turnover and job reallocation in Taiwanese manufacturing 0 0 0 29 2 3 10 193
Total Journal Articles 9 20 72 3,506 244 371 1,775 15,377


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Behavioral economics and the conduct of benefit–cost analysis: towards principles and standards 0 0 0 5 4 4 14 58
Valuing Health and Longevity in Regulatory Analysis: Current Issues and Challenges 0 1 1 9 2 4 6 34
Total Chapters 0 1 1 14 6 8 20 92


Statistics updated 2026-11-12